Pharmacokinetics of lopinavir and ritonavir in patients hospitalized with coronavirus disease 2019 (COVID-19)

…, B Jilma, T Stimpfl, M Karolyi… - Annals of internal …, 2020 - acpjournals.org
Background: The coronavirus disease 2019 (COVID-19) pandemic has rapidly spread
around the world, and the lack of effective treatment has fueled a global search for the “magic …

Influenza virus infection: an approach to identify predictors for in-hospital and 90-day mortality from patients in Vienna during the season 2017/18

E Pawelka, M Karolyi, S Daller, C Kaczmarek, H Laferl… - Infection, 2020 - Springer
Background Seasonal influenza outbreaks are associated with increased mortality and
hospitalisation rates. Herein we tried to identify predictors of mortality in hospitalised patients with …

Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2

…, JH Aberle, M Redlberger-Fritz, M Karolyi… - Science translational …, 2020 - science.org
Superspreading events shaped the coronavirus disease 2019 (COVID-19) pandemic, and
their rapid identification and containment are essential for disease control. Here, we provide a …

[HTML][HTML] Age related differences in monocyte subsets and cytokine pattern during acute COVID-19—A prospective observational longitudinal study

…, M Traugott, C Schörgenhofer, T Seitz, M Karolyi… - Cells, 2021 - mdpi.com
The COVID-19 pandemic drastically highlighted the vulnerability of the elderly population
towards viral and other infectious threats, illustrating that aging is accompanied by …

COVID‐19 fatality prediction in people with diabetes and prediabetes using a simple score upon hospital admission

…, M Clodi, P Fasching, M Karolyi… - Diabetes, Obesity …, 2021 - Wiley Online Library
Aim To assess predictors of in‐hospital mortality in people with prediabetes and diabetes
hospitalized for COVID‐19 infection and to develop a risk score for identifying those at the …

Performance of severe acute respiratory syndrome coronavirus 2 antibody assays in different stages of infection: comparison of commercial enzyme-linked …

…, JH Aberle, H Griebler, M Karolyi… - The Journal of …, 2020 - academic.oup.com
We comparatively assessed sensitivities and specificities of 4 commercial enzyme-linked
immunosorbent assays (ELISAs) and 2 rapid tests in 77 patients with polymerase chain …

[HTML][HTML] COVID-19 in-hospital mortality in people with diabetes is driven by comorbidities and age—propensity score-matched analysis of Austrian national public …

…, A Bräuer, C Ciardi, M Clodi, P Fasching, M Karolyi… - Viruses, 2021 - mdpi.com
Background: It is a matter of debate whether diabetes alone or its associated comorbidities
are responsible for severe COVID-19 outcomes. This study assessed the impact of diabetes …

Muscle involvement in SARS‐CoV‐2 infection

L Pitscheider, M Karolyi, FR Burkert… - European journal of …, 2021 - Wiley Online Library
Background and Purpose Since the outbreak of the severe acute respiratory syndrome
coronavirus‐2 (SARS‐CoV‐2) pandemic, several reports indicated neurological involvement in …

[HTML][HTML] High dose lopinavir/ritonavir does not lead to sufficient plasma levels to inhibit SARS-CoV-2 in hospitalized patients with COVID-19

M Karolyi, S Omid, E Pawelka, B Jilma… - Frontiers in …, 2021 - frontiersin.org
Background: Despite lopinavir/ritonavir (LPV/RTV) demonstrating in-vitro activity against
SARS-CoV-2, large trials failed to show any net clinical benefit. Since SARS-CoV-2 has an …

[HTML][HTML] Platelet phenotype analysis of COVID-19 patients reveals progressive changes in the activation of integrin αIIbβ3, F13A1, the SARS-CoV-2 Target EIF4A1 and …

…, C Schoergenhofer, T Seitz, M Karolyi… - Frontiers in …, 2021 - frontiersin.org
Background: The fatal consequences of an infection with severe acute respiratory syndrome
coronavirus 2 are not only caused by severe pneumonia, but also by thrombosis. Platelets …